CIS/Index
Copyright © 1999, Congressional Information
Service, Inc.
99 CIS H 27192
TITLE: Drugstores on
the Net: The Benefits and Risks of On-Line Pharmacies
CIS-NO: 99-H271-92
SOURCE: Committee on Commerce. House
DOC-TYPE: Hearing Retrieve
the full text of testimony
DATE: July 30, 1999
LENGTH:
iii+285 p.
CONG-SESS: 106-1
ITEM-NO: 1019-A-01; 1019-B-01
SUDOC: Y4.C73/8:106-51
SUMMARY:
Committee Serial No. 106-51. Hearing before the Subcom on Oversight and
Investigations to review risks and benefits to consumers of pharmaceutical sales
over the Internet. Examines regulatory issues raised by online
pharmaceutical sales, including sales by unlicensed online
pharmacies that dispense drugs without requiring individuals to
previously obtain a prescription from a personal physician.
Supplementary material (p. 28-30, 196-222, 283-285) includes correspondence,
a witness's written replies to Subcom questions, and a submitted statement.
CONTENT-NOTATION: Pharmaceutical sales over the
Internet, regulatory issues
DESCRIPTORS:
SUBCOM ON
OVERSIGHT AND INVESTIGATIONS, COMMERCE. HOUSE; MEDICAL REGULATION; TRADE
REGULATION; PHARMACISTS AND PHARMACY; LICENSES; PHYSICIANS;
CONSUMERS; INTERNET; DRUGS
99-H271-92 TESTIMONY NO: 1
July 30, 1999 p. 9-27, 31-44
WITNESSES (and
witness notations):
YUI, ELLEN
MICHEL, BOB (both online pharmacy users)
EGAN, KATHY (NBC 10, Philadelphia, Pa)
BEHRENS, CHRISTINE (Reporter, WWMT-News 3, Grand
Rapids-Kalamazoo, Mich)
STOVALL, CARLA J. (Attorney
General, Kansas)
STATEMENTS AND DISCUSSION:
Views on risks and benefits of online pharmaceutical
sales; details of Kansas lawsuit against online drugstores that dispense drugs
without prescriptions.
CONTENT NOTATION:
Pharmaceutical sales over the Internet,
regulatory issues
TESTIMONY DESCRIPTORS:
KANSAS ATTORNEY GENERAL'S OFFICE; LAWSUITS; KANSAS
99-H271-92 TESTIMONY NO: 2 July 30,
1999 p. 44-195, 223-246
WITNESSES (and witness notations):
BERNSTEIN, JODIE (Director, Bureau of Consumer Protection,
FTC)
FONG, IVAN K. (Deputy Associate Attorney General,
Department of Justice)
WOODCOCK, JANET (Director, Center
for Drug Evaluation and Research, FDA)
STATEMENTS AND DISCUSSION:
Overview of represented agencies efforts to mitigate risks
associated with online pharmaceutical sales (related materials, p. 52-86);
review of regulatory issues regarding online pharmaceutical sales, with
recommendations; perspectives on jurisdictional issues related to regulation of
online pharmacies.
INSERTION:
-- FDA, "Interagency Meeting: Online Sales of Medical
Treatments and Products -- Enforcement Issues" Apr. 26, 1999 (p. 135-147).
CONTENT NOTATION:
Pharmaceutical sales over
the Internet, regulatory issues
TESTIMONY
DESCRIPTORS:
FEDERAL TRADE COMMISSION; FOOD AND DRUG
ADMINISTRATION; FEDERAL INTERAGENCY RELATIONS; LAW ENFORCEMENT; DEPARTMENT OF
JUSTICE; JURISDICTION
99-H271-92 TESTIMONY NO: 3
July 30, 1999 p. 246-283
WITNESSES (and
witness notations):
CATIZONE, CARMEN A. (Executive
Director/Secretary, National Association of Boards of Pharmacy)
ABROMOWITZ, HERMAN I. (Board Member, AMA)
CULMO, CYNTHIA T. (Director, Drugs and Medical Devices
Division, Texas Department of Health)
RAZZOUK, WILLIAM
(Chairman and CEO, PlanetRx.com)
NEUPERT, PETER (President
and CEO, drugstore.com)
STATEMENTS AND DISCUSSION:
Perspectives on regulation of online pharmaceutical sales,
with recommendations; benefits of online pharmaceutical sales by licensed
pharmacies.
CONTENT NOTATION:
Pharmaceutical sales over the Internet,
regulatory issues
TESTIMONY DESCRIPTORS:
AMERICAN MEDICAL ASSOCIATION 
